UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 14, 2014

REVOLUTIONS MEDICAL CORPORATION

(Exact name of registrant as specified in its charter)

Nevada

000-28629

73-1526138

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

1124 Park West Blvd. Suite #102

Mount Pleasant, SC 29466

(Address of Principal Executive Offices)

(843) 971-4848

Registrant’s telephone number, including area code

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01 Other Events.

On November 14, 2014, Revolutions Medical Corporation (the “Company”) filed a Quarterly Report on Form 10-Q for the three months ended on September 30, 2014, in which the Company stated that KBM Worldwide Inc. (“KBM”) is an affiliate of Asher Enterprises, Inc. (“Asher”). The Company hereby amends such statement and clarifies that KBM and Asher are neither related parties nor affiliation of each other.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	REVOLUTIONS MEDICAL CORPORATION

Date: November 19, 2014	By:	/s/ Rondald L. Wheet
		Rondald L. Wheet
		Chief Executive Officer

Revolutions Medical CORP 8-K